Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

Using a vaccine ... therapeutic effect.” Importantly for a smaller-scale biotech such as Vaccitech having partners in Cancer Research UK and Ludwig will allow it to leverage the clinical trial ...

With the first therapeutic ... cancer vaccines, with more than ten such products — designed to confer active, specific immunotherapy directed against tumour-associated antigens — in Phase III ...

This supports the idea that we can make an immunotherapy that works in pancreatic cancer. Bolstered by these findings, Dr. Balachandran and MSK colleagues launched a clinical trial in 2019 to test a ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As clinical trials advance ... are fuelled by the therapeutic areas that ...

QS-21 is currently being evaluated as an adjuvant for many different vaccine candidates ... QS-21 is in clinical trials, of which several are in late-stage development by Antigenics' licensees ...

New results from the phase 1 clinical trial show that the therapeutic cancer vaccine activated tumor-specific immune cells that persisted in the body up to nearly four years after treatment in some ...

With the help of mRNA technology proven effective during the COVID era, researchers are now closer than ever to creating ...

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

This interview has been edited for length and clarity. WIRED: There are currently hundreds of mRNA cancer vaccine trials ongoing worldwide. How did the success of mRNA Covid vaccines kickstart this?

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...

(WTNH) — In Friday’s Health headlines, it’s kidney cancer awareness month. As we raise awareness about the disease, a new Yale-led study involving a personalized therapeutic vaccine provided ...